NCT02893293View on ClinicalTrials.gov

Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions
Osteonecrosis
Interventions
DRUG

Ferumoxytol-enhanced magnetic resonance imaging

Eligible patients receive a single ferumoxytol-dose and follow-up magnetic resonance imaging to evaluate success of stem cell transplant

DEVICE

Magentic Resonance Imaging

Both arms will receive MRI

Trial Locations (1)

94305

Lucile Packard Children's Hospital, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT02893293 - Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI | Biotech Hunter | Biotech Hunter